ARQT three-lens brief
Evidence-based stock research on ARQT. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved +3.63% yesterday. · P/E of 123 — priced for high growth; little margin of safety.
- Moved +3.63% yesterday.
- 50-day MA above 200-day MA (golden-cross regime); price above both.
- P/E of 123 — priced for high growth; little margin of safety.
- Analyst mean target $40.38 — 42% above current (8 analysts).
- Reported earnings on 2026-11-04.
ARQT closed at $28.38 (+3.63%) as of 2026-11-12. Market cap: $3.59B. P/E (trailing) 123.4. Price is above the 50-day MA and above the 200-day MA. Positives: moved +3.63% yesterday.; 50-day MA above 200-day MA (golden-cross regime); price above both.. Concerns: p/E of 123 — priced for high growth; little margin of safety.. Last quarter: Revenue $143.92M, net income $8.80M, free cash flow $32.62M.
Why three lenses on ARQT, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ARQT across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/ARQT" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ARQT brief"></iframe>